IMD Health Global announce strategic partnership with The Leukemia and Lymphoma Society of Canada to provide credible disease information resources into the hands of care providers, their patients and family members
January 6, 2022
IMD Health Global (IMD) is pleased to announce an important new partnership with The Leukemia & Lymphoma Society of Canada (LLSC). IMD is a CloudMD Software & Services company focused on digital health education, to provide their resources to healthcare providers, patients and their families on the IMD platform.
“People affected by a blood cancer deserve to have access to accurate information, resources and tools they need to make informed decisions about their health,” said Nadine Prevost, LLSC’s Senior Director, Community Services. “Our partnership with IMD can help support disease awareness and education, advance healthcare equity across the country, and help transform the blood cancer experience for so many Canadians.”
IMD Health is the largest digital health educational platform in Canada. IMD offers innovative technology that facilitates meaningful dialogue between healthcare professionals and patients inside the examination room, hospital bedsides, pharmacy consultations and during virtual consultations. IMD’s award-winning platform enables healthcare professionals to instantly access over 110,000 educational graphics, videos and resources at the point of care, across Canada.
“We are very excited to collaborate with LLSC to provide our clinicians, patients and their families with trusted information to improve their understanding of leukemia, lymphoma, and other blood cancers,” said Alice Haidau, Medical Content Manager, IMD, citing the need for accurate, reliable health information, particularly given the shift toward digital tools incited by the pandemic, and internet use which often leads to misinformation.
Through a resource like IMD, full of user-friendly and visually appealing information, healthcare providers, their patients and families will gain a better understanding and management of leukemia, lymphoma, and other blood cancers in Canada.
About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society of Canada (LLSC) is the single largest voluntary health agency dedicated to blood cancers in Canada. LLSC funds life-saving blood cancer research across the country and provides information and support services free of charge to people affected by a blood cancer and their families. Our mission is to cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of Canadians affected by blood cancers. For personalized disease, treatment or support information, contact our local support staff at 1-833-222-4884. Follow us on Facebook, Twitter and Instagram. Visit llscanada.org for more.
For further information, contact:
Maja Begovic
Director, Marketing and Communications
416-731-9338
About IMD Health Global
IMD Health Global is a Toronto-based eHealth software development company, focused on innovating healthcare education. Since 2010, IMD has grown into Canada’s largest digital patient engagement platform. Centred “At The Point of Care” ®, healthcare professionals use IMD’s cloud-based platform (in clinic or virtual consults) to engage with their patients at a deeper level and optimize knowledge transfer surrounding a patient’s condition and treatment plan. This is done through the seamless integration of over 110,000 images, booklets, and video resources, (covering 5,600 health topics) into an award-winning user interface that makes patient education both efficient and effective. At the end of a patient’s consult, a summary of all the discussed information can be emailed to the patient to review and continue their learning journey at home, improving their health literacy and adherence to their treatment plan. The IMD platform is utilized by over 14,300 practitioners (doctors, nurses and pharmacists in, clinics, hospitals, pharmacies, infusion clinics and in homecare settings. For more information please visit: www.IMDhealth.com and https://app.IMDhealth.com IMD Health is a subsidiary of CloudMD Software & Services (TSXV: DOC)
For more information, contact Jared Sonnenberg, VP jared.sonnenberg@IMDhealth.com
About CloudMD Software & Services
CloudMD is transforming the delivery of healthcare using technology and by providing a patient-centric approach, with an emphasis on continuity of care. By leveraging healthcare technology, the Company is building one, connected platform that addresses all points of a patient’s healthcare journey and provides better access to care and improved outcomes. Through CloudMD’s proprietary technology, the Company delivers quality healthcare through a holistic offering including hybrid primary care clinics, specialist care, telemedicine, mental health support, healthcare navigation, educational resources, and artificial intelligence (AI). CloudMD’s Enterprise Health Solutions Division includes the leading Student Assistance Program and one of the top 4 Employee Assistance Programs in Canada and offers one comprehensive, digitally connected platform for educational institutions, corporations, insurers, and advisors to better manage the health and wellness of their students, employees, and customers.
CloudMD currently services a combined ecosystem of over 7,000 psychiatrists, approximately 4,500 therapists and counsellors, approximately 4,000 psychologists, over 22,000 family physicians, over 34,000 medical specialists, over 1,500 allied health professionals, over 500 clinics, and over 5 million individuals across North America. For more information visit: https://investors.cloudmd.ca
